Trial Profile
Phase III Clinical Study on ART-123 in patients with disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections (Multicenter double-blind randomized parallel group comparative study with heparin sodium as control drug)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Thrombomodulin alfa (Primary) ; Heparin
- Indications Disseminated intravascular coagulation; Embolism and thrombosis
- Focus Registrational; Therapeutic Use
- Sponsors Asahi Kasei
- 05 Nov 2010 New trial record.